GTC Biotherapeutics (fka GTCB)

[joethdo]

The fact that they haven't cut back to a bare bones cash hoarding company is because something is in the works. I wish I knew what it was but in this case perhaps no news is good news.

I think we'll see one more significant deal before February 2009 when we can hope for the approval of ATRYN in the US,